We are live on
!
Find out more
Viridian Therapeutics
VRDN
VRDN
178 hedge funds and large institutions have $1.75B invested in Viridian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 42 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 42
75% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 24
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
8% more funds holding
Funds holding: 165 → 178 (+13)
1.06% more ownership
Funds ownership: 113.88% → 114.94% (+1.1%)
12% less capital invested
Capital invested by funds: $1.98B → $1.75B (-$233M)
52% less call options, than puts
Call options by funds: $9.76M | Put options by funds: $20.4M
Holders
178
Holders Change
+13
Holders Change %
+7.88%
% of All Funds
2.34%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
42
Increased
79
Reduced
42
Closed
24
Calls
$9.76M
Puts
$20.4M
Net Calls
-$10.6M
Net Calls Change
-$11.6M
Top Buyers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$30.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$24.8M |
| 4 |
BlackRock
New York
|
+$20.8M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$17.7M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$44.6M |
| 2 |
PA
Perceptive Advisors
New York
|
-$28.8M |
| 3 |
PBA
Paradigm Biocapital Advisors
New York
|
-$23.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$15.6M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$15.1M |
